Margaret M Byrne
Overview
Explore the profile of Margaret M Byrne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
1399
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Poudel R, Dougan S, Yates H, Sawyer L, Martinez U, Brandon K, et al.
Contemp Clin Trials
. 2025 Jan;
150:107827.
PMID: 39880329
Background: Augmented Reality (AR) is a rapidly developing technology with potential utility for treating addictive behaviors, including tobacco smoking. AR inserts digital images into a natural real-time scene as viewed...
2.
Studts J, Thurer R, Studts C, Byrne M
Transl Behav Med
. 2025 Jan;
15(1).
PMID: 39817729
Background: Results of the National Lung Screening Trial create the potential to reduce lung cancer mortality, but community translation of lung cancer screening (LCS) has been challenging. Subsequent policies have...
3.
Reblin M, Walters K, Rountree O, Witte D, Choi H, Zebrack B, et al.
J Palliat Med
. 2024 Dec;
28(3):371-376.
PMID: 39630568
Caregivers are engaging in recreational travel with the neuro-oncology patients they care for, yet there is little scientific research on this phenomenon. The purpose of this study is to examine...
4.
Byrne M, Hirsch E, Hoover K, McCoy J, Blair C, Futrell M, et al.
JTO Clin Res Rep
. 2024 Nov;
5(12):100728.
PMID: 39564096
Introduction: Translating outcomes from randomized trials of lung cancer screening into community practice settings has been challenging. We developed a framework-the Engaged Approach to Lung Cancer Screening (EA-LCS)-for improving adherence...
5.
Byrne M, Sutamtewagul G, Zeitler W, Mott S, Zamba G, Kojadinovic A, et al.
Front Oncol
. 2024 Aug;
14:1303268.
PMID: 39144826
Background: Patients with small cell lung cancer (SCLC) often respond to first-line chemoimmunotherapy. However, relapse is inevitable and is associated with a poor prognosis. Treatments for relapsed SCLC, such as...
6.
Mason N, Joshi V, Adashek J, Kim Y, Shah S, Schneider A, et al.
Eur Urol Oncol
. 2023 Feb;
6(3):331-338.
PMID: 36797084
Background: The treatment landscape for metastatic renal cell carcinoma (mRCC) has significantly evolved in recent years. Without direct comparator trials, factors such as cost effectiveness (CE) are important to guide...
7.
Brown S, Aitken W, Lombard J, Wang K, Rundek T, Byrne M, et al.
J Stroke
. 2023 Jan;
25(1):173-176.
PMID: 36592966
No abstract available.
8.
Clamon G, Byrne M, Talbert E
Cancers (Basel)
. 2022 Nov;
14(21).
PMID: 36358681
Cachexia is a common complication of cancer and is associated with poor quality of life and a decrease in survival. Many patients with cancer cachexia suffer from inflammation associated with...
9.
Reblin M, DAlmeida H, Barrios-Monroy V, McCormick R, Rodriguez L, Walters K, et al.
Support Care Cancer
. 2022 Oct;
30(12):10263-10272.
PMID: 36207640
Patient navigation is increasingly common in cancer care. While navigation programs often involve informal family caregivers, few navigation interventions specifically target the family caregiver. We developed the eSNAP and Caregiver...
10.
DeFreitas C, Carr S, Merck D, Byrne M, Linden O, Stiles E, et al.
Plast Reconstr Surg
. 2022 Aug;
150(5):1084-1089.
PMID: 35998125
Background: Craniosynostosis is typically diagnosed postnatally. Prenatal diagnosis would allow for improved parental counseling and facilitate timely intervention. Our purpose was to determine whether prenatal ultrasound can be used to...